MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The role of network connectivity in shaping the progression of cortical atrophy in Parkinson’s disease

    A. Vo, C. Tremblay, S. Rahayel, Y. Yau, A. Dagher (Montreal, Canada)

    Objective: We aimed to map the progression of cortical thinning and to test whether this pattern is constrained by network connectivity in the brain. Background:…
  • MDS Virtual Congress 2021

    The Effect of Darkness on Gait Parameters in Patients with Parkinson’s disease.

    P. Anukoolwittaya, P. Panyakaew, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To determine the effect of light on gait parameters in PD and compare to controls. Background: Falling in patients with Parkinson’s disease (PD) mostly…
  • MDS Virtual Congress 2021

    Longitudinal changes of gait parameters in early Parkinson’s disease

    V. Marković, I. Stanković, S. Radovanović, I. Petrović, T. Stojković, V. Kostić (Belgrade, Serbia)

    Objective: To analyse changes in quantitative gait parameters in patients with very early, unilateral, PD over 12 months follow-up. Background: Parkinson’s disease (PD) is frequently characterized by progressive gait…
  • MDS Virtual Congress 2021

    Prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative cohort.

    P. Beach, J. Mckay (Atlanta, USA)

    Objective: To assess prevalence of neurogenic and peripheral orthostatic hypotension (nOH/pOH) in the PPMI (https://www.ppmi-info.org) idiopathic Parkinson disease (PD) cohort and to examine whether nOH,…
  • MDS Virtual Congress 2021

    Is dopamine replacement therapy an addictive drug?

    V. Fleury, E. Pirondini, C. Provins, D. Benis, D. Vandeville, P. Krack (Geneva, Switzerland)

    Objective: To identify common clinical and imaging abnormalities in Parkinson's disease patients and heroin-dependent patients compared with healthy controls in order to better understand the pathophysiology…
  • MDS Virtual Congress 2021

    Data-driven prediction of fatigue in Parkinson’s disease patients

    DG. Lee, M. Mirian, L. Adrian, A. Yu, S. Neilson, K. Sundvick, E. Golz, L. Folger, S. Appel-Cresswell (Vancouver, Canada)

    Objective: The overall aim of this study is to identify which items of the Fatigue Severity Scale (FSS) best predict clinically significant fatigue in male…
  • MDS Virtual Congress 2021

    Dopamine dysregulation syndrome in Parkinson’s disease after COVID-19. Case report.

    A. Nikitina, D. Degterev (Moscow, Russian Federation)

    Objective: To describe a case of a man with Parkinson’s disease (PD), who was developed dopamine dysregulation syndrome (DDS) after COVID-19. Background: Parkinson’s disease is…
  • MDS Virtual Congress 2021

    The effect of deep brain stimulation on impulse control related disorders in Parkinson’s disease – a retrospective review of 137 patients

    H. Shepherd, S. Healy, N. Mooney, A. da Costa, M. Bonello, D. Damodaran, J. Panicker, B. Hammersley, J. Somerset, P. Eldridge, J. Osman-Farah, S. Alusi, A. Macerollo (Liverpool, United Kingdom)

    Objective: To assess the effect of deep brain stimulation on impulse control related disorders on patients with Parkinson’s Disease (PD) at our centre. Background: Approximately…
  • MDS Virtual Congress 2021

    Conception of a sensor- and home-based measurement of camptocormia

    R. Wolke, K. Naderi Beni, H. Wolframm, R. Rieger, N. Margraf (Kiel, Germany)

    Objective: This conception aims to outline the medical and technical requirements and a possible setup for an inertial-measurement-unit (IMU) quantifying camptocormia over a longer period…
  • MDS Virtual Congress 2021

    Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.

    H. Gonzalez-Usigli, A. Gonzalez-Vazquez, J. Garcia-Rivera, O. Padila-Delatorre, A. Leon-Gil, H. Gonzalez-Rodriguez (Guadalajara, Mexico)

    Objective: To find any relationship between cardiovascular risk factors such as diabetes mellitus, hypertension or both and worse state in patient with PD measured with…
  • « Previous Page
  • 1
  • …
  • 116
  • 117
  • 118
  • 119
  • 120
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley